The QualityStocks Daily Monday, July 13th, 2020

Today's Top 3 Investment Newsletters

Penny Pick Finders (EQ) +730.72%

QualityStocks (GAXY) +122.22%

OTCtipReporter (ECOR) +109.41%

The QualityStocks Daily Stock List

BriaCell Therapeutics Corp. (BCTXF)

NetworkNewsWire, Zacks, Small Cap Voice, Financhill, Street Insider, GlobeNewswire, Investing News, Morningstar, Stock Day Media, docoh, Canadian Insider, Stock News Now, Proactive Investors, Barchart, TMXmoney, MarketWatch, Seeking Alpha, Stockhouse, Nasdaq, Stocks to Buy Now, Wall Street Analyzer, InvestorsHub, Ceo.ca, OTC Markets, YCharts, and GuruFocus reported earlier on BriaCell Therapeutics Corp. (BCTXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer. The Company’s dedication is to enhancing the lives of women who are facing limited breast cancer therapy options. Its mission has been to develop novel immunotherapies to fight cancer. Incorporated in 2006, BriaCell Therapeutics has its Canadian corporate office in West Vancouver, British Columbia. Its U.S. corporate office is in Berkeley, California. The Company lists on the OTC Markets.

Immunotherapies have become the vanguard of the cancer treatments because they use the body’s immune system to destroy the cancer cells. This offers the potential for higher levels of safety and efficacy than chemotherapy and which may prevent cancer recurrence. Bria-IMT™ (SV-BR-1-GM) was designed by BriaCell’s team of scientists and clinicians. The Company’s proprietary whole-cell based technology platform continues to show its potential for treating breast cancer patients. BriaCell Therapeutics’ lead product candidate, Bria-IMT™ has been shown to stimulate components of the immune system in advanced breast cancer patients. The Company maintains rights for Bria-IMT™.

Regarding Bria-IMT™ Monotherapy, in a preliminary Phase I clinical study in advanced breast cancer patients who had failed multiple treatments, treatment with Bria-IMT™ considerably decreased tumor size, without serious side effects. Regression of breast cancer was observed in other sites including the lung and the brain. The median lifespan of the patients was significantly longer than anticipated in these advanced breast cancer patients.

At present, BriaCell Therapeutics has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates. With this agreement, Incyte and BriaCell will be evaluating novel combinations of compounds from Incyte’s development portfolio with BriaCell’s drug candidates in advanced breast cancer patients.

Also, capitalizing on insights gained with Bria-IMT™ and BriaDX™, BriaCell Therapeutics is developing Bria-OTS™, the first “off the shelf” personalized immunotherapy for the treatment for advanced stage breast cancer. Moreover, BriaCell’s small molecule program consists of novel, selective protein kinase C delta inhibitors that have shown activity in pre-clinical models of a number of cancers and fibrotic diseases.

Furthermore, regarding a combination Study of Bria-IMT™ with KEYTRUDA®, BriaCell Therapeutics recently announced a Grant to Investigator, Dr. Saveri Bhattacharya, at Sidney Kimmel Cancer Center – Jefferson Health for a Phase I/IIa Combination Study of Bria-IMT™ with KEYTRUDA® (manufactured by Merck & Co., Inc. (NYSE: MRK)) in advanced breast cancer.

Recently, BriaCell Therapeutics announced that it filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) outlining compositions and methods of developing novel multi-valent decoy receptors for diagnosis and treatment of coronavirus infection. The patent application, entitled “Multi-Valent Decoy Receptors For Diagnosis And/Or Treatment Of Coronavirus Infection”, describes a platform to generate multi-valent molecular constructs (decoy receptors), which have the potential to prevent coronaviruses including the SARS-CoV-2 virus (the virus that causes Coronavirus Disease 2019 (COVID-19)) from entering (infecting) healthy host cells.

BriaCell Therapeutics Corp. (BCTXF), closed Monday's trading session at $4.32, off by 12.0163%, on 205 volume with 3 trades. The average volume for the last 3 months is 423 and the stock's 52-week low/high is $0.022454999/$20.3600006.

Green Stream Holdings, Inc. (GSFI)

Financial Buzz, CRWE World, Accesswire, GuruFocus, OTC PR Wire, Stock Wave, Market News First, OTC Markets, TipRanks, Stockopedia, Baystreet.ca, Stockhouse, Investing.com, InvestorsHub, Insider Financial, Stockwatch, Simply Wall St, Investors Hangout, Newsfilecorp, Market Screener, Seeking Alpha, Nasdaq, Barchart, Dividend Investor, The Stock Market Watch, and GlobeNewswire reported beforehand on Green Stream Holdings, Inc. (GSFI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Green Stream Holdings, Inc. is a holding company of Green Stream Finance, Inc. It centers on currently unmet markets in the solar energy space by way of its inventive proprietary solar product offerings, financed for customers via its public and private partnerships. Green Stream Finance, Inc. is a Wyoming-based corporation with satellite offices in Malibu, California, and New York, New York. Currently, it is licensed in California, Nevada, Arizona, Washington, New York, New Jersey, Massachusetts, New Mexico, Colorado, Hawaii, and Canada. Green Stream Holdings is based in Pacific Palisades, California.

Green Stream's next-generation solar greenhouses are built and managed by Green Rain Solar, LLC, a Nevada-based division. The solar greenhouses use proprietary greenhouse technology and trademarked design developed by world-renowned architect Mr. Anthony Morali.

Green Stream is currently targeting high-growth solar market segments for its advanced solar greenhouse and advanced solar battery products. The Company has a growing presence in the considerably underserved solar market in New York, New York. There, it is targeting 50,000 to 100,000 square feet of rooftop space for the installation of its solar panels.

Green Rain Solar is the branded public face of the Green Stream Holdings ecosystem. It primarily engages in the construction of bespoke commercial solar projects and solar-powered greenhouses for rooftop agriculture or aquaponics (the symbiotic cultivation of aquatic life and vegetation). Green Rain installations will generate revenues through the sale of solar energy and also access to cultivation facilities within its greenhouses.

Green Stream Finance is a community shared solar model where the benefits of solar energy creation can be shared among the residents of a community. The Company states that this model has proven very effective at "democratizing" the value of energy produced through rooftop or quasi-local solar farms by permitting local residents to buy access to the energy proceeds through the local utility provider through customer contracts. In June, Green Stream Holdings announced that it secured a total of $7.8 million in contracts for the Community Solar model recently rolled out. The Projects are mainly located in the Northeast. The contracts represent Annual Revenue in excess of $300,000.00 and monthly clear Cash Flow of $26,000.00.

Moreover, at the beginning of July, Green Stream announced that it secured two new Community Solar Project agreements with CubeSmart Self Storage of Hackensack, New Jersey. The new locations are anticipated to produce an additional $6.6 million in Revenues, which is in addition to the earlier announced $3.9 million totaling $9.9 million for the entire project over a period of 25 years.

Last week, Green Stream announced that all owners of record on August 15, 2020, will be receiving Ten Shares of restricted common stock for every one hundred shares they own as of the Record Date.

Green Stream Holdings, Inc. (GSFI), closed Monday's trading session at $0.0367, up 14.6875%, on 415,472 volume with 33 trades. The average volume for the last 3 months is 243,865 and the stock's 52-week low/high is $0.027249999/$2.76999998.

n

Marker Therapeutics, Inc. (MRKR)

Market Chameleon, TipRanks, BioSpace, BioPharmCatalyst, iwatchmarkets, Investor Village, YCharts, Investing.com, Barchart, MacroTrends, TMXmoney, Stockhouse, InvestorsHub, Simply Wall St, Market Screener, Fosters Research, Trade Ideas, Finviz, Zacks, Equity Clock, GuruFocus, Finbox, Street Insider, Ceo.ca, ChartMill, Proactive Investors, Analyst Ratings, PR Newswire, Nasdaq, MarketWatch, Seeking Alpha, Morningstar, Stocktwits, and Dividend Investor reported earlier on Marker Therapeutics, Inc. (MRKR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A clinical-stage immuno-oncology company, Marker Therapeutics, Inc. specializes in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. The Company is also developing unique peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, and PolyStart™, a proprietary nucleic acid-based antigen expression technology designed to improve the ability of the immune system to recognize and destroy diseased cells. Marker Therapeutics lists on the NasdaqGM. The Company is based in Houston, Texas.

Marker Therapeutics developed its lead product candidates from its MultiTAA T cell technology that is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens (TAAs), which are tumor targets, and then kill tumor cells expressing those targets. The design of these T cells are to recognize numerous tumor targets to produce broad-spectrum anti-tumor activity.

Marker is advancing two MultiTAA T cell pipelines. One is its autologous T cells for the treatment of lymphoma, multiple myeloma, and selected solid tumors. The other is its allogeneic T cells for the treatment of acute myeloid leukemia, or AML, and acute lymphoblastic leukemia, or ALL. Because the Company does not genetically engineer its MultiTAA therapies, it believes that its product candidates are easier and less costly to manufacture, with reduced toxicities, than present engineered CAR-T and T cell receptor-based therapies, and may provide patients with meaningful clinical benefit.

In June, Marker Therapeutics announced that the United States Adopted Names (USAN) Council approved "zelenoleucel" as the nonproprietary (generic) name for MT-401, a multi-tumor-associated antigen (MultiTAA)-specific T cell product candidate for the treatment of patients with acute myeloid leukemia (AML) following allogeneic stem cell transplant in adjuvant and active disease settings.

Mr. Peter L. Hoang, President & Chief Executive Officer of Marker Therapeutics, said, "The USAN approval of zelenoleucel as the generic name for MT-401 is another step forward for continued advancement of our therapy. MT-401, which received Orphan Drug designation from the U.S. FDA in April, has shown clinical benefit in patients with acute myeloid leukemia post stem cell transplant in an investigator-sponsored trial. We are excited about the continued clinical development of zelenoleucel and look forward to initiating our Company-sponsored Phase 2 study in patients with AML following transplant."

Recently, Marker Therapeutics announced that it executed a lease agreement to establish a cGMP manufacturing facility in Houston, Texas, in an area near the George Bush Intercontinental Airport. The facility will allow production according to U.S. Food and Drug Administration (FDA) guidelines. The design of the facility is to be scalable using modular processes. The expectation is that the facility will be completed by year-end and operational in 2021.

Marker Therapeutics, Inc. (MRKR), closed Monday's trading session at $1.75, off by 8.377%, on 377,505 volume with 1,431 trades. The average volume for the last 3 months is 558,444 and the stock's 52-week low/high is $1.33000004/$9.17000007.

NuVista Energy Ltd. (NUVSF)

TeleTrader, Capital Cube, Street Insider, TipRanks, Invest Tribune, Tech Know Bits, EnergyNow.ca, Macroaxis, Investors Hangout, Morningstar, Wallet Investor, Dividend Investor, Dividata, GlobeNewswire, Stockhouse, Invezz.com, Market Screener, Nasdaq, TMXmoney, MarketWatch, and FX Empire reported earlier on NuVista Energy Ltd. (NUVSF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NuVista Energy Ltd. is an oil and natural gas company listed on the OTC Markets. It engages in the exploration for, and the development and production of, oil and natural gas reserves in the Western Canadian Sedimentary Basin. The Company’s chief emphasis is on the scalable and repeatable condensate-rich Montney formation in the Alberta Deep Basin (Wapiti Montney). Founded in 2003, NuVista Energy has its head office in Calgary, Alberta.

NuVista Energy’s goal is to operate with a high working interest (WI) ownership. This enables the Company to control the pace of development, minimize costs and cycle times between ideas and cash flow, and permits NuVista to accurately forecast the timing and magnitude of its efforts.

NuVista is advancing its Wapiti Montney condensate-rich natural gas resource play. This play has robust economics and considerable upside potential. Condensate is vital to the heavy oil business as heavy oil bitumen must be combined with condensate to create the viscosity required to allow transportation on pipelines. Condensate sales account for greater than 60 percent of NuVista Energy Revenues.

Regarding Wapiti Montney, the Company holds rights in roughly 166,720 gross acres of land that are prospective for the Triassic Montney formation with an approximate working interest (WI) of 89.8 percent. The Montney formation in this area is typified by high rate condensate-rich natural gas.

NuVista Energy also has about 1,600 Boe/d of net production from different other Triassic zones on 52,800 net acres of non-Montney land. These Assets are to the northeast of the Pipestone Montney acreage. They comprise largely non-operated, low decline unit production with below industry average asset retirement obligations.

Additionally, included is a 39 percent operated WI in the area gathering and compression system and the Wembley gas plant. NuVista also has non-core operations in three additional areas of Alberta whose combined production in 2017 averaged 900 Boe/d in comparison to 2,761 Boe/d in 2016 because of asset divestitures and production decline.

In late May, NuVista Energy announced that its bank syndicated credit facility limit was redetermined at $475 million. This compares to the previous limit of $550 million. The Company expects to have more than adequate liquidity for the rest of this year, as it plans to spend less than anticipated adjusted funds flow for the rest of this year.

As noted earlier, NuVista Energy has the productive capacity to manage production roughly flat to first quarter levels, 50,000 to 52,000 Boe/d, for the rest of 2020. Nonetheless, the Company said that uncertainty around oil prices and curtailment makes it difficult to predict its planned level of production through the second and perhaps third quarters. Therefore, NuVista withdrew its production guidance for 2020.

NuVista Energy Ltd. (NUVSF), closed Monday's trading session at $0.547, off by 4.3204%, on 4,711 volume with 10 trades. The average volume for the last 3 months is 38,433 and the stock's 52-week low/high is $0.170000001/$2.48015999.

Oculus VisionTech, Inc. (OVTZ)

Ask Finny, TradingView, Whale Wisdom, Infront Analytics, Dividend Investor, hot Stocked, Wallet Investor, Stock Day Media, CSI Market, Dividend.com, Simply Wall St, GuruFocus, Equity Clock, Market Screener, YCharts, Valuu Analytics, Stockhouse, Nasdaq, Stockwatch, Proactive Investors, Morningstar, Barchart, Seeking Alpha, MarketWatch, MarketBeat, docoh, and Seeking Alpha reported earlier on Oculus VisionTech, Inc. (OVTZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Oculus VisionTech, Inc. is a cyber security company listed on the OTC Markets. It creates systems for document and multimedia protection to fight tampering and digital piracy. The Company was established by experts in image processing and is operated by an experienced management team. Oculus VisionTech has its corporate office in Vancouver, British Columbia. The Company previously went by the name USA Video Interactive Corp. It changed its name to Oculus VisionTech, Inc. in January of 2012.

The Company has created a Cloud-based document protection system based on embedded digital watermarking. It has done so utilizing proprietary technology originally created for embedding digital watermarking video-on-demand (VOD) systems. Oculus VisionTech’s systems, services, and delivery solutions include document, still image and motion video digital watermark solutions and documents, photographs (still image) and video content protection.

Oculus is recognized as one of the leaders in forensic watermarking. Technology such as Anti-Tampering have been pioneered as part of its efforts to remain a leader in forensic watermarking. At present, the Company is promoting the imaged-based Document Protection System (DPS) and developing a number of other products.

Oculus has developed Document Watermarking Protection technology. It is provided as a Cloud service – Cloud DPS. The Cloud DPS is a system made to protect and authenticate digital documents from tampering. It is meant for documents at the end of the editing cycle.

This past June, Oculus VisionTech announced that it has expanded its technology reach into the global data privacy compliance market. Through the recent acquisition of OCL Technologies Corporation (OCLT) of San Diego, California, Oculus will help organizations around the world to manage and monitor their data privacy compliance obligations to meet EU GDPR, CCPA, SB220 and other upcoming international privacy rights initiatives and legislation.

In addition, in June, Oculus VisionTech reported the appointment of Mr. Fabrice Helliker as a Director to the Company. Mr. Helliker is presently an advisor to OCL Technologies Corp., which was recently acquired by Oculus. He is a long time executive and entrepreneur in the data protection and compliance market.

Oculus VisionTech, Inc. (OVTZ), closed Monday's trading session at $0.205, off by 33.4847%, on 658,102 volume with 208 trades. The average volume for the last 3 months is 209,265 and the stock's 52-week low/high is $0.07/$0.483999997.

Sandfire Resources America, Inc. (SRAFF)

Caesars Report, Junior Mining Network, Market Screener, Mining Technology, Stockopedia, Proactive Investors, Stock Pulse, Street Insider, YCharts, FX Empire, TradingView, Simply Wall St, Investors Hub, Annual Reports, Stockhouse, and Northern Miner reported beforehand on Sandfire Resources America, Inc. (SRAFF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sandfire Resources America, Inc. acquires, explores for, and develops resource properties in the USA and Canada. The Company explores for copper, cobalt, zinc, lead, and silver deposits. Its flagship property is the Black Butte copper project. The Company previously went by the name Tintina Resources, Inc. It changed its name to Sandfire Resources America, Inc. in January of 2018. Founded in 1998, Sandfire Resources America is headquartered in White Sulphur Springs, Montana.

The Black Butte Copper Project will be an underground mine. The Black Butte copper project consists of roughly 7,684 acres of fee-simple lands and 4,541 acres in 239 Federal unpatented lode-mining claims located in central Montana. Situated north of White Sulphur Springs, the project’s property includes the Johnny Lee Deposit, which contains a copper concentration 10 times higher than many existing mines.

The Johnny Lee deposit has a Measured and Indicated Mineral Resource of 10.9 million tonnes (Mt) at an average copper grade of 2.9% for 311 thousand tonnes (kt) of contained copper (Cu) at a 1.0 % Cu cut-off grade. In addition, the Johnny Lee deposit has an Inferred Mineral Resource of 2.7 Mt at an average copper grade of 3.0% for 80 kt of contained Cu at a 1.0 % Cu cut-off grade.

Forty-eight diamond drill holes completed by Sandfire Resources America have been used to update the Mineral Resource estimate for the Johnny Lee deposit. Metallurgical testing of the deposit has been integrated with systematic mineralogy to develop a copper recovery model. The updated copper cut-off grade of 1.0 % Cu is based upon updated recovery studies and price assumptions.

On May 19, 2020, the Montana Department of Environmental Quality (MT DEQ) issued a Phase I bonding number establishing a bond of $4.65 million for the Black Butte Copper Project. Sandfire Resources America must secure this bond before starting surface construction at the mine site. The initial bond increment covers only Phase 1 surface construction of the mine site. At present, Sandfire is finalizing a construction contract for the start of surface earthworks that are scheduled to begin this summer after Sandfire secures the Phase I bond amount.

Sandfire Resources America, Inc. (SRAFF), closed Monday's trading session at $0.17, even for the day, on 8,075 volume with 6 trades. The average volume for the last 3 months is 88,042 and the stock's 52-week low/high is $0.104999996/$0.309300005.

Whitecap Resources, Inc. (SPGYF)

Easy Trading Signals, Simply Wall St, Whale Wisdom, StocksBeat, Tech Know Bits, Dividend.com, Analyst Ratings, 4-Traders, Seeking Alpha, Capital Cube, Stock Pulse, OTC Markets, Street Insider, Barchart, Wallmine, Stockhouse, Macroaxis, AA Stocks, Dividend Investor, Morningstar, Investing.com, Wallet Investor, Stockwatch, TMXmoney, TipRanks, and Mining.com reported beforehand on Whitecap Resources, Inc. (SPGYF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Whitecap Resources, Inc. acquires and develops petroleum and natural gas properties in Canada. The Company’s main properties are in West Central Alberta, Northwest Alberta and British Columbia, Southeast Saskatchewan, West Central Saskatchewan, and Southeast Saskatchewan. Since inception in September of 2009, Whitecap Resources has accumulated a substantial light oil resource base that provides a strong foundation for continued growth and results on a per share basis. Listed on the OTC Markets, Whitecap Resources is headquartered in Calgary, Alberta.

The Company’s concentration is on providing sustainable dividends and profitable per share growth enhanced by value added acquisitions. Whitecap is an oil-weighted growth company. It pays a monthly cash dividend to its shareholders. Important attributes to its growth and dividend strategy include a focus on organic per share growth (5-8 percent annually) within funds flow, supplemented with value adding acquisitions. In addition, its attributes include a large development drilling inventory of high netback light oil. Attributes also include strong capital efficiencies in concentrated areas.

Whitecap Resources employs a strategy of acquiring sustainable assets with large Discovered Petroleum Initially In Place (DPIIP) and low current recovery factors and moving them through the development chain through converting contingent resources - probable reserves - proven reserves - producing reserves (cash flow). The Company’s asset portfolio has stable production and low base declines. This provides Whitecap’s shareholders with a predictable cash flow stream for monthly dividend payments. Furthermore, the large resource in place enables the Company to grow on a per share basis.

Whitecap Resources’ Cardium producing areas in West Central Alberta are chiefly in the Pembina, Garrington, Ferrier, and Willesden Green areas. Regarding its Viking assets, its Lucky Hills, Whiteside, Kerrobert, and Eagle Lake areas are in West Central Saskatchewan. The Company’s Southwest Saskatchewan assets are concentrated west of Swift Current, Saskatchewan. They are characterized by predictable low base decline, medium crude oil (21° API) production.

Whitecap’s Boundary Lake property is mainly in northeast British Columbia on the Alberta/British Columbia border, just east of Fort St. John. Its Deep Basin properties, which include Karr, Simonette, Kakwa, Elmworth and Wapiti, are southwest of Grande Prairie, Alberta. Its Weyburn property is in southeast Saskatchewan. The principal reservoirs undergoing development are the Midale and Frobisher.

This past June, Whitecap Resources released its 2020 Environmental, Social and Governance (ESG) Report on its website, demonstrating the Company’s commitment to sustainable growth and industry leadership. It is the operator and majority owner of the Weyburn unit in southeast Saskatchewan where in 2019 it safely and responsibly injected 2.0 million tonnes of CO2 underground versus its total direct and indirect CO2 emission of 1.4 million tonnes.

Moreover, Whitecap Resources has established a target to decrease its direct emissions intensity 20 percent by 2023 from 2019 levels. The Company chose 2019 as a base year for this target to center on new decreases rather than accounting for decreases already attained. Since 2017, Whitecap has already lessened its emissions intensity by 37 percent. When the Company reaches its target in 2023, this will result in a 50 percent reduction overall.

Whitecap Resources, Inc. (SPGYF), closed Monday's trading session at $1.57309, off by 4.0857%, on 61,064 volume with 46 trades. The average volume for the last 3 months is 87,665 and the stock's 52-week low/high is $0.499500006/$4.37010002.

Altura Mining Limited (ALTAF)

TipRanks, OilandGas360, HotCopper, Wallmine, YCharts, Invest Tribune, Investing News, Insider Financial, Stock Invest, and Micro Small Cap reported earlier on Altura Mining Limited (ALTAF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Altura Mining Limited engages in the exploration and development of mineral properties in Australia and Indonesia. The Company operates via Coal Mining, Lithium Mining, Exploration Services, and Mineral Exploration segments. In addition, Altura provides drilling services to mining and exploration companies. Altura Mining is based in Perth, Australia.

Altura is an important player in the worldwide lithium market and is taking advantage of growing demand for raw materials for manufacturing lithium ion batteries for electric vehicles (EVs) and static storage uses. The Company is concentrating on the construction and development of its 100 percent owned Pilgangoora Lithium project positioned in the Pilbara region of Western Australia. The Pilgangoora Project is a producing lithium operation.

Altura's mine at Pilgangoora produced first lithium in July of 2018. First sales were in October of 2018, and commercial production was declared in March of this year. The project, at Pilgangoora in Western Australia, is roughly a 123 km drive from the town of Port Hedland. The Pilgangoora Mining Lease tenements, encompassing the resource modelling area, are M45/1230 and M45/1231 and cover an area of 394 hectares.

The mining operation at Pilgangoora consists of an open pit mine, processing plant and support infrastructure. At full production the mine will produce roughly 220,000 tonnes of lithium spodumene concentrate per annum.

The life of mine is forecast to be 26 years at present rates. However, at the request of Altura Mining’s offtake partners, the Company has completed a definitive feasibility study for expansion study of the project. This proposed Stage 2 expansion will result in mine output increasing to 450,000 tonnes annually. Start of Stage 2 is subject to Altura Mining entering long term offtake agreements with customers, securing funding for the expansion, and also final Board approval.

For May 2019, Altura Mining had record monthly production of 15,737 wmt, representing 86 percent of planned nameplate capacity. The current quarter has delivered strong sales with 24,881 dmt of product shipped, with a further minimum 13,000 dmt scheduled this month. Recent production numbers have demonstrated a considerable improvement in the performance of the process plant that has seen the project attain multiple daily record production levels at or above the nameplate capacity.

Altura Mining Limited (ALTAF), closed Monday's trading session at $0.07, up 75.00%, on 98,070 volume with 12 trades. The average volume for the last 3 months is 15,563 and the stock's 52-week low/high is $0.009999999/$0.119999997.

Delrey Metals Corp. (DLRYF)

Micro Small Cap, Streetwise Reports, Stock Target Advisor, Street Signals, Geology for Investors, Investing News, InvestorsHub, Mining Stock Education, Stockhouse, Stockwatch, Investorx, Investor Ideas, and Junior Mining Network reported earlier on Delrey Metals Corp. (DLRYF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A mineral exploration company, Delrey Metals Corp. is working to capitalize on the growing demand for Energy Metals. The Company is focusing on the acquisition, exploration and development of mineral resource properties, specifically in the strategic energy minerals space. It has an option to earn an 80 percent interest in the Four Corners Project located in Newfoundland & Labrador. Delrey continues to review and acquire projects showing potential for materials used in the energy storage and electric vehicle markets. Delrey Metals lists on the OTC Markets and the Company is based in Vancouver, British Columbia.

Delrey Metals’ Four Corners Project is an advanced stage Fe-Ti-V exploration project. It has positive historic drilling, metallurgy, as well as development economics. In addition, Delrey recently acquired the Star, Porcher, Peneece and Blackie Fe-Ti-V properties situated along tidewater in western British Columbia.

The Four Corners Project consists of 7655.0 hectares and is positioned in southwestern Newfoundland and Labrador, 25km east of the town of Stephenville. The Project is host to vanadium enriched titaniferous magnetite (iron) mineralization that shows encouraging historical evidence for considerable and consistent vanadium accumulations across five main target zones.

The Blackie vanadium property is located in west-central British Columbia, in the Skeena Mining Division, about 96km south-southwest (straight-line distance) from Prince Rupert. The property comprises 5 tenures encompassing 1213.2 Ha. It is open for expansion in numerous directions.

The Peneece vanadium project is situated at the head of Seymour Inlet, southwest British Columbia, The property comprises 5 tenures covering 1500.4 Ha. It is also open for expansion in multiple directions. The Porcher vanadium property is in west-central British Columbia, in the Skeena Mining Division. The property comprises 7 tenures encompassing 3122.16 Ha. It is open for expansion in manifold directions.

The Star property is located in west-central British Columbia, in the Skeena Mining Division. This property comprises 4 tenures encompassing 3646.8 Ha and is open for expansion in multiple directions. Moreover, the Sunset Project had historical drilling done in 1991 and it totaled 393.5m over 2 holes. The target currently sought at the Sunset claims is a volcanogenic massive sulphide deposit, similar to Britannia or a vein and replacement type gold-silver deposit similar to Northair or Brandywine.

Today, Delrey Metals provided a corporate update regarding 2019 exploration activities on its flagship Fe-Ti-V Four Corners Project Stephenville, Newfoundland and Labrador, and also its wholly-owned Peneece property near Port Hardy, British Columbia. The Company is to complete up to 5,000m of drilling over a proposed 20 drill holes, and 1,600m of trenches on the Four Corners Project during the 2019 exploration season. Work will focus on the Keating Hill East, Four Corners, and Bullseye Zones.

The design of 2019 drilling is to complete infill and step out drill targets as necessary to advance project towards a maiden NI 43-101 resource calculation. 2012 initial SRK Consulting (Canada) Inc.'s metallurgical results returned a magnetic concentrate grading 63.10% Fe, and 0.643% V205, and also a low intensity magnetic concentrate returning a notable 26.80% Ti02, at an 80% recovery. Furthermore, Delrey has completed a Phase I airborne geophysics survey across its wholly-owned Fe-Ti-V Peneece property located near Port Hardy, British Columbia.

Delrey Metals Corp. (DLRYF), closed Monday's trading session at $0.2229, up 62.5346%, on 20,112 volume with 9 trades. The average volume for the last 3 months is 3,529 and the stock's 52-week low/high is $0.000099999/$0.242489993.

Galaxy Next Generation, Inc. (GAXY)

Simply Wall St, Wallet Investor, Dividend Investor, GuruFocus, GlobeNewswire, Teletrader, Market Screener, Modest Money, Barchart, The Street, Investors Hangout, Corporate Information, Last10k, MarketWatch, and Street Insider reported on Galaxy Next Generation, Inc. (GAXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Galaxy Next Generation, Inc. (GAXY) is a U.S. distributor of interactive learning technology hardware and software, which create totally collaborative instructional environments. The Company’s products include its own private-label interactive touch screen panel and many other national and international branded peripheral and communication devices. Galaxy Next Generation has its corporate headquarters in Toccoa, Georgia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Galaxy Next Generation’s distribution channel includes more than 22 resellers across the United States. These resellers mainly sell the Company’s products within the commercial and educational market. Typically, the K-12 education market is the largest customer base for Galaxy Next Generation products. This market comprises close to 90 percent of the Company's sales.

The Company works together with educators to help them develop teaching and learning in their Connected Classrooms. This new approach takes advantage of digital content, learning data, and one-of-a-kind technologies to create an immersive and interactive experience.

Galaxy’s products include interactive panels, collaboration devices, panel accessories, and integrated PCs. The Company’s software includes Ximbus and Oktopus. In addition, Galaxy offers an assortment of on-site training opportunities. The Company also focuses on premier after sales services.

In March, Galaxy Next Generation announced a new product offering where it has started to use online training resources for its products and customers. Mr. Gary LeCroy, Galaxy Next Generation’s Chief Executive Officer, said, “We now have reference cards available for the software and hardware, step by step instructions on using the software and hardware, and we are even offering onsite training at the customers school or place of business as part of their purchase.”

Furthermore, in March, Galaxy Next Generation announced that Newton County, Georgia, School District, a prior purchaser of G2 panels, will continue to purchase the Company’s G2 panel as a standard. Mr. LeCroy said, "We are excited to be the official company awarded Newton County School District’s G2 panel contract. It is always edifying to have an existing customer see the continued value of our products.”

Galaxy Next Generation, Inc. (GAXY), closed Monday's trading session at $0.006, up 122.2222%, on 760,795,873 volume with 5,113 trades. The average volume for the last 3 months is 30,626,795 and the stock's 52-week low/high is $0.002199999/$2.83999991.

Alternate Health Corp. (AHGIF)

Wallet Investor, Weed Newswire, GuruFocus, CannabisFN, OTC Markets, Marijuana Index, Stockhouse, MicroCapFinder, OTC Insider, MarketWatch, InvestorsHub, The Street, Daily Marijuana Observer, Investing News, Trading View, Cannabis Life Network, and Market Screener reported earlier on Alternate Health Corp. (AHGIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Alternate Health Corp. is a global cannabis company listed on the OTC Markets’ OTCQB. It provides software solutions for the medical cannabis industry. The Company utilizes best in class technology, research, education, production, and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. Alternate Health has its headquarters in Toronto, Ontario. The Company has additional offices in Venice and Humboldt County, California and San Antonio, Texas.

Alternate Health is a diversified healthcare investment and Holdings Company. It operates via a network of subsidiaries that share proprietary, highly secure cloud-based software solutions to increase efficiencies and protect patient data. Its companies are: Alternate Health Clinics; Alternate Health Labs; Alternate Medical Media; Alternate RX; CanaPass, Inc.; and VIP-Patient.

Alternate Health develops software applications and processing systems for the medical industry employing proprietary technology platforms (VIP-Patient & CanaPass systems) to assist doctors in their practice management and patients with their need for first-rate medical care. Alternate Health’s services include practice management and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the developing medical cannabis industry.

The Company has transformed the CanaPass Patient Management system to a total Ethereum-based blockchain Electronic Medical Records (EMR)/Electronic Health Records (HER) system. Alternate Health has taken a leadership position in blockchain financial and healthcare solutions. CanaPass, Inc. provides turnkey compliance management software to doctors and Licensed Providers of medical cannabis and other controlled substances.

A key product is its Zi App Blockchain Payment Gateway. The design of it was originally to enable digital payments in cannabis. However, the system has earned considerable interest as a payment solution for even larger markets. This includes multi-level marketing, commercial leases, as well as equipment rentals.

Recently, Alternate Health announced that Mr. Kyle Kemper was appointed to the Company's Board of Directors. Mr. Kemper is the author of "The Unified Wallet: Unlocking the Digital Golden Age", which is a definitive work on the implications of blockchain technology in the modern world. He is a strong advocate for the expansion of blockchain and Bitcoin.

Mr. Howard Mann, Chief Executive Officer of Alternate Health, said, "We are thrilled to welcome Mr. Kemper to Alternate Health's Board of Directors. His deep technical knowledge, vision for what's possible and network of industry contacts are valuable assets to the Company as we take the lead in both blockchain technology and cannabis."

Alternate Health Corp. (AHGIF), closed Monday's trading session at $0.083, up 107.50%, on 42,550 volume with 4 trades. The average volume for the last 3 months is 11,771 and the stock's 52-week low/high is $0.029999999/$0.227740004.

FogChain Corp. (FOGCF)

StockReads, Stock Orange, Stockwatch, Bullish Guru, Penny Stock Hub, Press Reader, Investors Hangout, 4-Traders, OTC Markets, InvestorsHub, MarketWatch, Barchart, Insider Financial, Stockhouse, TradingView, Market Screener, and Wallet Investor reported previously on FogChain Corp. (FOGCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FogChain Corp. is a completely integrated, end-to-end software development life cycle (SDLC) and quality assurance solutions provider. The Company’s set of services and technology provides application development at scale with more speed, efficiency and at a lesser cost. FogChain's Build-Once Deploy-Everywhere software architecture provides developers with a set of tools and resources that bridges devices, operating systems, and the ability to build and launch new applications in a unified environment. OTCQB-listed, FogChain is based in Vancouver, British Columbia.

FogChain has acquired RadJav, which provides developers with fast application development tools and resources for the creation of mobile and web apps, smart contracts, and dApps. These are to be used across all major operating systems and devices on a unified platform. In addition, FogChain also acquired Quilmont - a growing and profitable software development solutions provider specializing in automated testing, Continuous Integration and Deployment (CI/CD), mobile and website development, and software quality assurance.

Fundamentally, FogChain provides a next generation platform. This platform seamlessly integrates application development and deployment that leverages a high-performance Fog (or Edge) based computing network to drive scale and connects with the unique and ground-up built RadJav Blockchain. FogChain is introducing the next generation of decentralized compute to the world of software development and application lifecycle management.

RadJav has completed the integration of Visual Studio Code (VS Code) into its platform. The RadJav platform provides fast application development tools and resources to build and launch applications across all devices, from PCs to tablets and smartphones, and also operating systems such as Linux, Windows, Mac OSX, and Apple's iOS - all using the same code.

Fog Computing utilizes decentralized and distributed computing resources and application services that are closer to the Edge, or actual point of use. Fog Computing integrates with the most current technologies. These include IoT (Internet of Things), Blockchain, 3D & Virtual Reality engines, and analytics tools. It can leverage underused resources, reducing costs.

FogChain announced this past November that it commercialized and launched its Automated Application Testing Platform, Test Case Manager (TCM), an enterprise grade software application testing solution. TCM is a patented automated testing product. It enables organizations to accomplish substantial cost savings and improved time to market through automating their test cases.

FogChain also reached an agreement to acquire AppMark's application monitoring and benchmarking platform (AppMon) and other related assets for the issuance of one million shares and $40,000 USD. AppMark (Redwood City, California) is a SaaS solutions provider. It specializes in synthetic performance monitoring of enterprise mobile, web, as well as desktop applications.

Recently, FogChain announced it completed work on an initial release of Trident. This is a unified cross-platform application development, testing and monitoring services platform. Trident's Build-Once-Deploy-Everywhere software architecture provides developers with a group of tools to build, test, and monitor new applications using a single code-base while being natively deployed across desktop, tablet, and mobile devices.

Trident will feature the ability to deploy virtual testing labs across an array of web browsers and all major operating systems. The containerized approach permits companies to scale their development, testing, and monitoring processes with minimal effort and considerable cost savings.

FogChain Corp. (FOGCF), closed Monday's trading session at $0.0187, up 70.00%, on 4,600 volume with 6 trades. The average volume for the last 3 months is 138 and the stock's 52-week low/high is $0.000099999/$0.076800003.

Natcore Technology, Inc. (NTCXF)

Stockhouse, InvestorsHub, MarketWatch, OTC Markets, Business Insider, and StreetInsider reported on Natcore Technology, Inc. (NTCXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natcore Technology, Inc. concentrates on using its proprietary Foil Cell technology to considerably lower the costs and improve the power output of solar cells. The Company is creating the next generation of solar cells. Natcore is developing two main technologies. These are low-cost, all-back-contact solar cell structures, and Black Silicon cells.

A solar R&D company, Natcore Technology is headquartered in Rochester, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s Foil Cell (All Back Contact Solar Cell) uses a high-speed, low temperature laser process. Natcore’s Black Silicon technology streamlines the path to low solar cell reflectance.

Natcore Technology has its Natcore Laboratory in Rochester. This is a 19,000 sq. ft. facility. It has 8,000 sq. ft. of ‘class 10,000’ clean room. The Company engages in the full solar cell process at this laboratory - from bare silicon wafer to working cells.

Regarding the Company’s Foil Cell Structure, the process involves multilayer foil metallization. Key features/properties include low cost contact metals and simplified manufacture. This includes low capital equipment cost, small factory footprint, and low temperature processing.

Natcore Technology has established exclusive licenses and/or joint research agreements with Rice University, the National Renewable Energy Laboratory (NREL), Fraunhofer ISE and the University of Virginia. The Company has received 33 patents; 32 patents are pending.

Yesterday, Natcore Technology announced it significantly streamlined the fabrication method for its pioneering Natcore Foil Cell™. This allows for even lower-cost production methods.

The Company is targeting greater than 25 percent real-world efficiency for its eventual production solar cells. This is approximately a 25 percent performance improvement over numerous high-end commercial cells being installed today.

The use of laser processing to create the Company’s unique, all-back-contact cell structure has been eliminated and replaced by a carrier selective contact process. This is combined with a foil metallization, which can be inexpensively made with high-speed roll-processing methods. Natcore has started an accelerated development program to produce a prototype with the new process, and also include production cost and efficiency modeling by independent authorities.

Natcore Technology, Inc. (NTCXF), closed Monday's trading session at $0.007, up 536.3636%, on 600 volume with 1 trade. The average volume for the last 3 months is 18,278 and the stock's 52-week low/high is $0.001099999/$0.0285.

MetaStat, Inc. (MTST)

Goldman Small Cap Research, Innovative Marketing, Club Penny Stocks Network, OTCBB Journal, First Penny Picks, StocksImpossible, Pumps and Dumps, and The MicrocapNews reported previously on MetaStat, Inc. (MTST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

OTCQB-listed, MetaStat, Inc. is a personalized medicine company developing therapeutic and diagnostic treatment solutions for cancer patients. The Company develops and commercializes diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis - the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body.  MetaStat’s focus is on breast, prostate, lung, and colorectal cancers, where systemic metastasis is responsible for approximately 90 percent of all deaths.

A life sciences company, MetaStat is headquartered in Boston, Massachusetts. In essence, MetaStat’s core expertise includes an understanding of the mechanisms and pathways that drive tumor cell invasion and metastasis, and also drug resistance to certain targeted therapies and cytotoxic chemotherapies.

  The basis of MetaStat’s function-based diagnostic platform technology is on the identification and understanding of the vital role of the mena protein and its isoforms  (a common pathway for the development of systemic metastatic disease in all epithelial-based solid tumors).

The design of the MetaSite Breast™ and MenaCalc™ product lines are to accurately stratify patients based on their individual risk of metastasis and to enable clinicians to better customize cancer treatment decisions through positively identifying patients with a high-risk of metastasis who need aggressive therapy and by sparing patients with a low-risk of metastasis from the damaging side effects and cost of chemotherapy. 

  The MetaSite Breast™ test measures the process of systemic metastasis. MenaCalc™, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is widely applicable in solid epithelial-based cancers.

The intention of the MetaSite Breast™ test is for use in patients with early stage (stage 1-3), invasive breast cancer who have node-negative or node positive (1-3), estrogen receptor-positive, HER2-negative disease.

In August of 2017, MetaStat announced that accomplished drug developer, Renato T. Skerlj, Ph.D., joined the Company as a member of its Scientific and Clinical Advisory Board. Dr. Skerlj has more than 25 years of pharmaceutical experience in drug development resulting in two marketed drugs: Invanz® and Mozobil® and numerous drugs in clinical development.

He serves as Vice President of Drug Discovery and Preclinical Development at Lysosomal Therapeutics Inc. Dr. Skerlj is a Co-Founder and a Member of the Scientific Advisory Board of X4 Pharmaceuticals, Inc. He is also Co-Founder of Noliva Therapeutics.

MetaStat, Inc. (MTST), closed Monday's trading session at $0.013, up 116.6667%, on 400 volume with 1 trade. The average volume for the last 3 months is 68 and the stock's 52-week low/high is $0.0023/$0.0625.

The QualityStocks Company Corner

Knightscope, Inc.

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc..

Knightscope, a company that designs and builds Autonomous Security Robots (“ASRs”) that provide 24/7/365 security in a variety of different locations, will be hosting a webinar on Saturday July 18, 2020 at 1 PM ET (10 AM PT). This is the last opportunity to ask Knightscope Chairman and CEO William Santana Li any due diligence questions before the current Reg A+ Investment Offering comes to an end on Monday July 20, 2020 at the current share price of $8.00. Questions will be answered live from Knightscope Headquarters in Silicon Valley. To register for the webinar, visit http://ibn.fm/4UZ8f

Knightscope, Inc., founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities and are on target to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics and artificial intelligence.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including ten Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country, despite the pandemic (note: robots are immune).

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire.

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology;
  • Operating for more than one million hours in the field and securing contracts across five time zones;
  • Navigating through the global pandemic without interruption by continuing to operate on a daily basis across the nation and supporting clients classified as essential services; and
  • Continuing its hiring processes despite the current societal and economic disruption.

Growth Capital

With more than 10,000 investors and over $40 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

The company is presently in the process of raising up to $50 million in growth capital as it prepares for a potential public listing. Knightscope has reserved ticker symbol ‘KSCP’ with Nasdaq.

Investors can buy shares exclusively through the company’s managing broker-dealer, StartEngine (http://nnw.fm/l9GLX) until July 20, 2020. Concurrent with this live offering and contingent upon various factors, including raising a sufficient amount of funds and meeting applicable listing standards, the company intends to begin preparation of an S-1 format Form 1-A and Nasdaq Capital Market application in anticipation of a possible public listing of the stock at the conclusion of the Regulation A+ offering.

Company Mission – The Greater Good

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting millions of law enforcement and security professionals across the country.

Crime has a negative economic impact in excess of $1 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was recently interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one to one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $4 to $11 per hour, compared with approximately $85 and $30 per hour for an armed off duty law enforcement officer and an unarmed security guard, respectively.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has four patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’.

The ASRs and all the related technologies were developed ground up by the Company and are Made in the USA.

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.


Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Monday's trading session at $12.88, up 11.0345%, on 15,847,524 volume with 105,540 trades. The average volume for the last 3 months is 1,336,574 and the stock's 52-week low/high is $1.472/$19.25.

Recent News

DarioHealth Corp. (NASDAQ: DRIO)

The QualityStocks Daily Newsletter would like to spotlight DarioHealth Corp. (DRIO).

DarioHealth Corp. (NASDAQ: DRIO) was featured today in a publication from BioMedWire, examining how, if you are a facility owner considering the different options available in the Electronic Health Record System space, you have probably heard or seen the term “SaaS” and “Hosted” to refer to different ways of licensing EHR products. These terms are always used interchangeably, and that should not be the case. If you have heard these terms from your vendors, then you need to understand the difference.

New York and Israel-based DarioHealth Corp. (NASDAQ: DRIO) leads global digital therapeutics (DTx) with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The company’s strategic advantages include:

  • AI-powered digital solutions that drive durable behavior change in chronic disease patients, and
  • Personalized user experience at scale to make behavior change the path of least resistance.

Approximately $3 trillion in annual U.S. costs associated with chronic illnesses like diabetes, hypertension and obesity are largely preventable with behavioral therapies. Formerly limited to periodic office visits, these therapies can now scale to millions with tech-enabled, continual and remote health monitoring, as well as AI-driven digital and live coaching. This is all possible while still maintaining the personalization required for success in reducing illness and its related effects and costs.

Roughly 51,000 active, paying users manage their health with Dario’s platform that combines smartphone-connected vitals measurement, remote patient monitoring (RPM), lifestyle management tools, and AI-driven and human coaching to deliver improved clinical outcomes.

Among the most downloaded medical apps, the Dario platform is rated at 4.9 stars on the Apple App Store and features 11,000 reviews, along with a Net Promoter Score (a measurement of consumers’ willingness to recommend the product to others) that’s the highest in its field.

Company Strategy

Clinical studies demonstrate Dario’s direct improvement on users’ health measures like H1AC scores (diabetes) and blood pressure (hypertension).

Patient engagement in therapies leads to health success. Dario’s platform centers on continual maximization of patient engagement through personalization, including ‘nudges’ and live, AI-generated responses to health measures provided by Dario’s smartphone-connected medical devices.

Proprietary data analysis provides valuable insights that not only improve health care providers’ medical capabilities but, through artificial intelligence, encourage patients to take evidence-based and highly personalized preventative measures that reduce risk, emergency room visits and preventable hospitalization.

Dario is now deploying its successful B2C platform in B2B2C, targeting employers and health plans with competitive advantages in cost, software and hardware.

The company estimates an annual addressable U.S. market of $72 billion, only 1% of which has been penetrated with digital therapeutics.

The strategic transition to B2B2C (from exclusively B2B) is intended to accelerate revenue growth by reducing Dario’s cost per acquisition per user and expanding margins.

Dario’s commitment to aggressive growth is also shown by its appointment of a new president, chief medical officer and head of sales for North America, all from a highflyer behavioral health company.

Key growth drivers planned include expansion of the company’s paying B2C subscriber base; lateral expansion into other chronic conditions that overlap with its core diabetes populations, such as hypertension, obesity and depression; and increased B2B2C penetration.

Financial Highlights

The company plans to leverage a massive opportunity for growth, with a global addressable market for digital therapeutics of roughly $108 billion. In the U.S. alone, that number is estimated at $72 billion, and only about 1% of that market has been penetrated.

Dario’s strategic transition to an SaaS membership business model increased gross profit by 87% in Q1 2020, as compared to the prior year. Membership revenue increased from 27.1% to 46.7% in the same period. The company is seeing improved operating efficiencies as it shifts focus to the B2B2C business model, and it expects average revenue per user per month (ARPU), which was $6 and $25 in 2019 and 2020, respectively, to reach $70.

Value to Consumers and Businesses

Dario continually evaluates and optimizes the value and return its platform delivers to consumers and businesses.

Consumers seeking to understand how their everyday behavior impacts their personal health and chronic conditions benefit from actionable feedback on how to improve health and better collaborate with health care providers.

Businesses looking to increase employee satisfaction, loyalty and productivity with fewer health-related absences take advantage of Dario’s services for employers.

Health care providers improve patient compliance using the platform’s interactive services that allow for greater monitoring, which improve engagement with patients at the right times and with the right treatments.

Health plans can leverage DarioHealth’s solutions to improve patient outcomes and lower costs.

Recent Studies

The company recently presented the results of two new studies at the American Diabetes Association’s 80th Scientific Sessions, which showed sustained improvements in blood glucose levels and blood pressure among users of its digital therapeutic platform for chronic diseases. The results of these two studies demonstrate that the use of Dario’s therapeutic platform promotes behavioral modification, enhanced individual engagement and improved clinical outcomes.

Remote Patient Monitoring (RPM) Agreements

The Centers for Medicare & Medicaid Services recently approved RPM codes for Medicare patients, which enables physicians to bill for between-visit patient care.

This simplifies implementation of the company’s open and scalable AI-driven platform and further supports transition to the company’s high-margin, recurring SaaS model targeting B2B2C revenue channels.

Emergency COVID-19 FDA Guidelines Allow Self-Test Blood Glucose Meters

In an effort to preserve personal protective equipment (PPE) and reduce contact between health care providers and patients in hospital settings due to COVID-19, the U.S. Food and Drug Administration (FDA) has recognized that home-use blood glucose meters, including Dario’s smartphone-connected metering device, may be used by patients with diabetes who are hospitalized due to COVID-19 to check their own blood glucose levels and provide the readings to the health care personnel caring for them.

As a result, hospitals can now allow patients to self-test using their Dario blood glucose testing strips and smartphone-connected devices, or hospitals can issue patients Dario devices upon admission for COVID-19-related conditions.

Irregularities in blood glucose levels are suspected as a factor in the increased severity of potentially deadly COVID-19 complications. As such, a high priority is being placed on stabilization of patients’ blood glucose levels.

Awards and Recognition

DarioHealth’s Blood Glucose Monitoring System was voted as the ‘Best Glucometer for Data Management’ by Top Ten Reviews. Jeph Preece, senior editor at Top Ten Reviews, said, “The Dario app is the best data management system that I’ve seen. Compared to apps by popular brands, Dario’s system looks and feels like it’s years ahead of the curve.”

‘The Global Digital Health 100’, an annual award sponsored by the reputable Journal of Health, recognized DarioHealth as a leader among health technology companies demonstrating the greatest potential to change the way that health care is delivered.

DarioHealth Corp. (DRIO), closed Monday's trading session at $7.00, up 1.4493%, on 55,548 volume with 196 trades. The average volume for the last 3 months is 72,152 and the stock's 52-week low/high is $3.01999998/$13.1260004.

Recent News

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) today announced that its U.S. leasing division, MUSA Auto Finance, LLC ("MUSA"), has obtained lease financing from a federally chartered U.S. depository financial institution ("National Funder") to begin leasing vehicles to U.S. consumers. According to the update, lease originations will begin today. To view the full press release, visit http://nnw.fm/1plOy

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Monday's trading session at $0.2197, up 20.5156%, on 262,967 volume with 46 trades. The average volume for the last 3 months is 81,930 and the stock's 52-week low/high is $0.038600001/$0.241600006.

Recent News

Cannabis Global, Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (MCTC).

Cannabis Global, Inc. (MCTC) was highlighted today in a publication by Wall Street PR, examining how CBD, or cannabidiol, continues to be a high-growth theme, with analysts looking for massive growth over coming years, including almost unheard of CAGR numbers heading out for a half-decade or more. The key behind the idea is something microeconomists call “mainstreaming” – when a new trend evolves from a micro-level affair to an everyday household theme across an economic system.

Cannabis Global, Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

Cannabis Global, Inc. (MCTC), closed Monday's trading session at $0.21785, up 0.206992%, on 27,654 volume with 20 trades. The average volume for the last 3 months is 68,568 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in the 420 with CNW by CannabisNewsWire. Federal prohibition has been a thorn in cannabis’ side for a long time. And even as tens of states move to legalize recreational and medical marijuana, it remains illegal at the federal level and this has held the industry back in many ways. For instance, state-legal cannabis cannot be considered ‘organic’, a title bestowed by the U.S. Department of Agriculture, even if the growers maintained the purported ‘organic’ standards while growing the crop. However, regulators in California, the largest legal cannabis market in the world, have unveiled proposed regulations for a program that would equal the federally bestowed ‘organic’ status.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $0.017, up 9.6774%, on 618,684 volume with 91 trades. The average volume for the last 3 months is 1,110,906 and the stock's 52-week low/high is $0.0092/$2.15000009.

Recent News

Wrap Technologies Inc. (NASDAQ: WRTC)

The QualityStocks Daily Newsletter would like to spotlight Wrap Technologies Inc. (NASDAQ: WRTC).

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that it is scheduled to train seven new agencies on the BolaWrap in Maryland on Tuesday, July 14, 2020. According to the update, Landover Hills Police Department will host the "Train the Trainer" session for 16 trainers from seven different local agencies. To view the full press release, visit http://nnw.fm/yYs9Y

Wrap Technologies Inc. (NASDAQ: WRTC) is an innovator of modern policing solutions. The company’s BolaWrap® product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar® tether to restrain an individual at a range of 10-25 feet. Developed by award-winning inventor Elwood Norris, the company’s chief technology officer, the small-but-powerful BolaWrap assists law enforcement in safely and effectively controlling encounters, especially those involving an individual experiencing a mental crisis.

Non-Lethal Weapons Market Potential

The BolaWrap Remote Restraint device is an innovative police solution, designed to provide law enforcement with a unique mobile and humane restraint option that does not inflict pain and enables subjects to be detained from a distance without the use of force.

In 2015, the 10 cities with the largest police departments in the United States paid out a cumulative $248.7 million in settlements and court judgements in police misconduct cases, marking a 48% increase from the $168.3 million in 2010 (http://nnw.fm/ri0L9). The majority of these cases have centered around the improper use of force by law enforcement when subjugating individuals, with 25% of all fatal shootings by law enforcement in the United States reportedly involving mentally ill individuals who are often incapable of comprehending officer commands (http://nnw.fm/YVm8P). Moreover, the use of alternate devices has failed to produce the desired outcomes, with the use of tasers by police resulting in over 1,080 fatalities since 2000 (http://nnw.fm/2Nb1A).

This, in turn, has led to a greater demand for humane tools which are not reliant on pain compliance to subdue subjects. Since its IPO in December 2017, Wrap Technologies has enjoyed a spectacular rise in prominence. The company began field testing the BolaWrap product in July 2018, with the first international order received only a month later, in August 2018. By December 2018, the company had been uplisted to the Nasdaq Capital Market with over 1,000 shareholders – a significant increase from the 50 shareholders who had participated in the IPO just 12 months prior. Recently, the company has sought to increase its commerciality and product monetization, appointing Tom Smith, the founder of TASER International (now Axon, NASDAQ: AAXN), as its president in March 2019.

At present, over 140 police departments throughout the United States are actively carrying the BolaWrap, while over 1,700 police departments across the nation have reached out to the company to request BolaWrap demonstrations, training and quotes. BolaWrap has also been successfully marketed internationally and has been shipped to 19 countries thus far.

As of today, Wrap Technologies has built a network of 11 distributors across 45 states in the United States who are actively marketing the product to the over 900,000 active police officers in the country. In addition, the company now has a network of 15 international distributors based in 26 countries – with over 600 international requests received thus far for product demonstrations, training and quotes.

As a result and following the opening of its new 11,000-square-foot manufacturing facility in Tempe, Arizona, in October 2019, Wrap Technologies announced a 352% year-on-year increase in revenues for 3Q2019 – a testament to the growing popularity of its mobile restraint device.

The company expects its growth to continue as adoption rates of the BolaWrap product increase throughout the United States and globally. According to a study by Stratistics MRC, the addressable global market for non-lethal weapons accounted for $6.32 billion in 2016 and is set to rise to $11.85 billion by 2023.

Product Received to Positive Acclaim

  • “An innovation that is changing the world of policing.” – Chief Luther Reynolds, Charleston Police Department
  • “Anytime you can have a more humane response to someone in crisis, it’s not only good for the department, it’s good for society.” – Redditt Hudson, Regional Field Director of the NAACP (http://nnw.fm/1STXm)
  • “This is going to save lives.” – Chief Ed Hudak, Coral Gables Police Department
  • “I see this as one of the great tools if you encounter someone with a mental health crisis.” – Chief Steven Casstevens, Buffalo Grove Police Department

Recently completed $12.4 million financing round

Wrap Technologies announced that it had successfully completed its capital raising round on June 4, 2020, raising $12.4 million through a primary share placement priced at $6.00/share. The net proceeds will be use to further scale engineering, fund product development and provide working capital to meet worldwide demand for BolaWrap products and accessories (http://nnw.fm/byLV7). The company also announced that its founder, Elwood Norris, had chosen to exercise 100,000 outstanding warrants to contribute $500,000 to the capital raising efforts. Following the financing round, Wrap Technologies reported over $30 million in cash on hand.

Management Team

Elwood G. “Woody” Norris, Founder and Chief Technology Officer
Elwood G. “Woody” Norris is an award-winning American inventor and serial entrepreneur and currently serves as chief technology officer for Wrap Technologies Inc. Norris founded and served as a director and president of Parametric Sound Corporation (now Turtle Beach Corporation (NASDAQ:HEAR)) and also served as chief scientist at Turtle Beach. Norris previously founded LRAD Corporation (NASDAQ: LRAD) and, prior to retiring in 2010, was chairman of LRAD Corporation’s board of directors, serving as a technical advisor and product spokesperson. Norris has authored more than 80 U.S. patents, primarily in the fields of electrical and acoustical engineering, and has been a frequent speaker on innovation to corporations and government organizations. He is the inventor of Wrap Technologies’ patented and patent pending BolaWrap® technology.

Scot Cohen, Executive Chairman
Scot Cohen has more than 20 years of experience in institutional asset management, wealth management, and capital markets. Cohen founded and served as principal of the Iroquois Capital Opportunity Fund, a closed-end private equity fund which focused on investments in North American oil and gas. Cohen also co-founded Iroquois Capital, a New York-based hedge fund that managed approximately $300 million across its family of funds. Prior to Iroquois Capital, Cohen founded a merchant bank which actively participated in structured investments in public companies. Cohen is currently active on a number of public and private company boards and is involved with various charitable ventures.

David Norris, Chief Executive Officer
David Norris is an experienced executive who joined Wrap Technologies full-time in January 2018. From April 2014 to December 2017, he served in various executive roles, including president, at privately held loanDepot LLC as it rapidly expanded into the fifth largest mortgage lender in the U.S. loanDepot had 6,000 employees and generated $1 billion in revenue in 2017. Norris also served as CEO of Greenlight Financial, and president of LendingTree Loans. Norris’ career also includes executive and management roles at Toshiba America Information Systems and Qualcomm Personal. Earlier in his career, Norris served as a probation officer in San Diego for five years.

Tom Smith, President
Tom Smith co-founded TASER International (now Axon Enterprise Inc. (NASDAQ: AAXN)) (“TASER”) in 1993 and served as president of TASER until October 2006. He served as chairman of the board of directors of TASER from October 2006 until he retired to pursue entrepreneurial activities in February 2012. Amongst his most significant roles and responsibilities at TASER, Smith managed domestic and international sales, significantly expanding the sale and distribution of TASER’s products, including sales to more than 17,200 federal, state and local law enforcement agencies in over 100 countries. In 2012, he founded Achilles Technology Solutions LLC, which, through subsidiary ATS Armor, developed a line of ballistic solutions for law enforcement and military applications. Smith holds a B.S. in ecology and evolutionary biology from the University of Arizona and an M.B.A. from Northern Arizona University.

Jim Barnes, Chief Financial Officer
Jim Barnes has served as president of Sunrise Capital Inc., a private venture capital and financial and regulatory consulting firm, since 1984. Barnes was chief financial officer of Parametric Sound Corporation (now Turtle Beach Corporation), and also served as vice president administration at Turtle Beach Corporation. Since 1999, Barnes has been manager of Syzygy Licensing LLC, a private technology invention and licensing company he owns with Elwood Norris. Barnes previously practiced as a certified public accountant and management consultant with Ernst & Ernst and Touche Ross & Co., and as a principal in J. McDonald & Co. Ltd. in Phoenix, Arizona.

Wrap Technologies Inc. (NASDAQ: WRTC), closed Monday's trading session at $10.98, off by 10.1473%, on 1,734,647 volume with 10,120 trades. The average volume for the last 3 months is 1,226,842 and the stock's 52-week low/high is $3.06999993/$14.1000003.

Recent News

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Growing health services provider Trxade Group (NASDAQ: MEDS) recently announced the expansion of its patient empowerment telehealth platform Bonum Health, which has added access to educational resources that can help better understand and direct their care management.

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Monday's trading session at $5.51, off by 3.0783%, on 8,467 volume with 124 trades. The average volume for the last 3 months is 55,015 and the stock's 52-week low/high is $3.23399996/$11.6000003.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX) was featured today in a publication from BioMedWire, examining how digital data collection has played major roles in several aspects of our lives, reduced waste and removed room for human error. For example, airlines today transfer most of the data collection function to their customers, and we are willing (and even happy) to use our mobile devices to provide all the needed data, such as our seat preferences and other personal details. Banks have done the same, and so have other service providers. However, the field of clinical research has been slow in waking up to the immense benefits of digital data collection, and we cover some of the major considerations why this should no longer be the case.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Monday's trading session at $2.90, off by 6.7524%, on 1,329,061 volume with 3,496 trades. The average volume for the last 3 months is 2,697,358 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

With the importance of big data on the rise, it should come as no surprise that the finance industry is leveraging the use of data analytics to deliver increased transparency and improve communications with stakeholders on every level. SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, is leveraging this trend through Sequire, its innovative investor intelligence platform. Through the use of proprietary technology, Sequire unlocks big data analytics in powerful new ways that connect public companies with traders and long-term investors for communication and marketing campaigns.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $2.30, off by 4.5643%, on 35,664 volume with 173 trades. The average volume for the last 3 months is 69,500 and the stock's 52-week low/high is $1.04999995/$4.8499999.

Recent News

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), today issued a corporate update. Among other items highlighted in the update, the Company continues to work with the British Columbia Securities Commission (the “Commission”) to complete its continuous disclosure review. Champignon Brands will continue to fully cooperate with the Commission to assist in completion of the review in a timely fashion. In addition, the Company’s board of directors, in June 2020, considered options for realizing additional value for the consumer-packaged goods (“CPG”) pillar of its business and contemplated a reorganization that would result in the spinout of this business into a new reporting issuer. At this stage, the board of directors has determined that this is not a suitable transaction to undertake and will not be proceeding with the contemplated reorganization and spinout. To view the full press release, visit http://ibn.fm/QitAI

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Monday's trading session at $0.51, off by 1.9231%, on 432,490 volume with 198 trades. The average volume for the last 3 months is 686,857 and the stock's 52-week low/high is $0.221/$1.74.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., today announced revenues of $131.4 million for the fiscal year ended April 2020, which represents a 53% increase of approximately $45.5 million compared to fiscal year 2019 revenues of $85.9 million. To view the full press release, visit http://nnw.fm/ve4P8

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.185, off by 11.6544%, on 312,503 volume with 61 trades. The average volume for the last 3 months is 131,939 and the stock's 52-week low/high is $0.0215/$0.249799996.

Recent News

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) was featured today in the 420 with CNW by CannabisNewsWire. For years, law enforcement and opponents of marijuana prohibition have argued that legalizing the controversial plant could lead to a surge in crime in neighborhoods hosting retail marijuana stores and spill over into neighboring states that still prohibit it. There have even been a few studies showing that this is indeed true, but according to researchers going through county-level crime data in municipalities neighboring two states which legalized marijuana, these studies may have been skewed. Ultimately, they found scant evidence that legalizing marijuana increased crime rates.

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Monday's trading session at $0.0031, off by 8.8235%, on 98,067,399 volume with 820 trades. The average volume for the last 3 months is 57,127,461 and the stock's 52-week low/high is $0.001599999/$0.021999999.

Recent News

InsuraGuest Technologies, Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Technologies, Inc. (TSX.V: ISGI).

InsuraGuest Technologies, Inc. (TSX.V: ISGI) is a leading global SaaS (Software-as-a-Service) company leveraging its proprietary, flagship insurtech (insurance + technology) software, InsuraGuest, which is integrated with the property management systems of hotels and vacation rentals to deliver custom Hospitality Liability coverages.

InsuraGuest’s Hospitality Liability coverages are purchased by hotels and vacation rental properties, which can address claims from guests and their room occupants. The combination of the integrated software and customized insurance provides the property liability coverages the guests benefit from in the event a loss is incurred during their stay.

The Hospitality Liability policy is offered through integration of InsuraGuest’s API with the clients’ property management systems. InsuraGuest’s platform is currently capable of integrating with approximately 71 different hotel and vacation rental property management systems, giving it access to millions of rooms worldwide.

InsuraGuest continues to pursue expansion opportunities in the United States, and has plans to expand to its distribution platform and Hospitality Liability coverages to the United Kingdom and Europe regions by third quarter 2020, as well as expansion into Asia by the end of 2020.

Protection that Enhances the Guest’s Experience

InsuraGuest’s Hospitality Liability coverages add a layer of protection for the property on a primary basis, should a guest experience an accident or theft while staying at an InsuraGuest member hotel or vacation rental property.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit that are not the properties fault.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Hospitality Liability policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Investment Consideration

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a Bachelor of Science in consumer studies with an emphasis in architecture as an undergraduate at the University of Utah. He subsequently earned his MBA. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Logan Anderson, CFO & Director
Logan Anderson (bachelor’s degree in communications, accounting and economics) holds the designation of ACA with the Chartered Accountants of Australia and New Zealand. He began his career as an associate chartered accountant in New Zealand and then Canada. This was followed by his position as controller of a management services company which was responsible for the management of numerous private and publicly traded companies. Since 1993, Anderson has served as president of Amteck Financial Corp. (and its predecessors), a private financial consulting services company servicing both private and public companies. He is a former director of 3D Systems, Inc. (NYSE: DDD), and was formerly a founder, officer, and director of Worldbid.com. Anderson has also been involved in raising funds for numerous private and public companies in all stages of their development and has been an officer and director for numerous public and private companies over the past 40 years.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends. Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Tony Sansone, COO & VP of Finance
Tony Sansone has over 30 years of financial, operations and business development experience which includes serving as CFO in the health care, foodservice distribution, manufacturing and technology sectors, including public company experience. He has held senior finance positions in the banking, telecommunications, medical products, and food & drug retailer industries, closing over $430 million of private debt, equity and line of credit financings and over $350 million of a merger, acquisitions, real estate and state incentive transactions, including due diligence, negotiations, closing, and integration. Sansone coordinated and was the executive sponsor for four ERP implementations and multiple other best-in-class software & technology solutions. He received his MBA from the University of Utah and a Bachelor of Science in accounting from Utah State University. Sansone also currently serves as president-elect of the Utah Chapter of Financial Executives International and a past president and current member of the board of trustees for Catholic Community Services of Utah. He is the proud father of three children.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018 and as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Jennifer Epperson, Vice President of Sales
Jennifer Epperson has over 20 years of B2B sales experience with exceptional success history. She has grown and developed sales territories across multiple industries. Her ability to find and develop strategic relationships has given her top-level performance throughout her career. Epperson’s passion and knowledge provide an inherent ability to connect and retain relationships for the growth of the company. Throughout her professional career, she has achieved peak performance sales results and awards year after year. She captures the vision of the company and drives it forward with enthusiasm and expertise. Her commitment to providing an exceptional customer experience has been the key to her success.

Richard Matthews, Interim Financial Controller
Richard Matthews joined the InsuraGuest team in March 2019 as the interim financial controller. Leading the Finance and Audit team, Matthews is responsible for the delivery of financial services such as accounting, treasury, reporting, budgeting and insurance management, in accordance with legislative requirements and organizational policies and strategies. He has over 30 years of experience in providing professional services across a broad range of finance areas including compliance, business process, audit, and financial reporting. He holds a degree in accounting from the University of Utah and is a licensed CPA in the state of Utah.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

Jim Kilduff, Board Advisor
James “Jim” C. Kilduff has nearly 40 years of experience in the insurance and risk management sectors. He is a dynamic and energetic team leader and builder with extensive experience in the changes affecting the insurance business through Gas, alternative distribution, insurtechs and program business. His skillset includes experience as chief insurance officer with Outdoorsy Insurance Group, CEO with Harbor Hill Solutions Inc., and senior vice president and chief marketing officer with State National Insurance Companies. His career has spanned MGA creation and management, insurance company management, business development and underwriting, primary insurance and reinsurance.

Don Archibald, Board Advisor
Don Archibald brings to InsuraGuest’s advisory board 54 years of experience as an insurance agent. Archibald is the founder and former owner of Archibald Clarke and Defieux (ACD Insurance), as well as the co-founder and former equity partner of Sussex Insurance, and an agent with Sussex since 2014.

InsuraGuest Technologies, Inc. (TSX.V: ISGI), closed Monday's trading session at $0.19, up 26.67%, on 16,500 volume with 7 trades. The average volume for the last 3 months is 9,881 and the stock's 52-week low/high is $0.045/$0.34.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.